Build the "Compute-Experiment-Feedback" ZHIYUE Flywheel

AIDP-X high-efficiency screening, validation cycle compressed from 6 months to 3 weeks

End-to-End AI Scenario Implementation Services

Computing services + Drug R&D platform + Automated lab management + General AI tools

General AI Tools: Activate Enterprise Data Value

Talent mapping, intelligence engine, knowledge base, contract hub

From Computing Infrastructure to AI Application Deployment

End-to-end delivery, one-stop service, subscription-based, pay-by-results

Drug Discovery Platform: AIDP-X & CADD Fusion Engine

Integrated 12 SOTA models, one-click execution, average 2.3 hours

Three Major Challenges in Biopharma AI Transformation

Talent Gap

12%

Only 12% of biology PhDs have AI skills, interdisciplinary talent commands >$140K annual salary

Data Silos

83%

83% of enterprise experimental data is unstructured, unable to connect to AI training

Unclear ROI

Wait-and-See

AI drug discovery business loop not fully validated, strong wait-and-see sentiment

ZHIYUE Flywheel: End-to-End AI Implementation

Five product lines comprehensively covering biopharma AI transformation needs

Computing Services

Solve high computing costs

  • Compute leasing/procurement/evaluation
  • Flexible deployment solutions
  • Cost optimization comparison
Learn More →

AI Cloud Platform

Improve computing utilization

  • One-stop development tools
  • Visual annotation
  • Zero-code inference deployment
Learn More →

Data Middle Platform

Break information silos

  • One-item-one-code traceability
  • Intelligent insights
  • Cross-institutional collaboration
Learn More →

AIDP-X Early Discovery Platform

Shorten target discovery time

  • CADD & AIDD synergy
  • Target validation closed loop
  • Lead compound optimization
Learn More →

General AI Tools

Activate existing data value

  • Knowledge base
  • Talent mapping
  • Intelligence engine
Learn More →

Real Data Validates Technological Transformation

Benchmark case study showcase

AIDP-X Platform Achievements

18 Months

IPF candidate drug from target discovery to clinical filing

$2.6M

Only 5% of traditional path cost

22.3%

Rentosertib Phase II clinical FVC improvement rate (p<0.01)

Watch Case Video

Eliminate 'Can't Transform, Dare Not Transform, Can't Afford' Concerns

Four service commitments for AI transformation

90-Day Quick Win Plan

3 quantifiable POC project deliveries

On-Site Expert Mechanism

Biology+AI dual-background consultants throughout

Performance Bet Agreement

Proportional refund if key metrics not met

Continuous Evolution Service

Quarterly model updates and scenario expansion

Ready to Start Your AI Transformation Journey?

Request a demo now and get your exclusive AI transformation plan

Request Expert Demo